Design, synthesis, and antiviral evaluation of novel hydrazone‐substituted thiophene[3,2‐<i>d</i>]pyrimidine derivatives as potent human immunodeficiency virus‐1 inhibitors
Zhao Wang(Shandong University), Xinyong Liu(Shandong University of Traditional Chinese Medicine), Zhipeng Huo(Shandong University), Erik De Clercq(Rega Institute for Medical Research), Gaochan Wu(Shandong University), Xiaofang Zuo(Shandong University), Dongwei Kang(Shandong University), Dirk Daelemans(Rega Institute for Medical Research), Zhongxia Zhou(Shandong University), Peng Zhan(Shandong University of Traditional Chinese Medicine), Meng Chen(Shandong Center for Disease Control and Prevention), Da Feng(Shandong University), Lanlan Jing(Shandong University), Tong Zhao(China Pharmaceutical University), Christophe Pannecouque(Rega Institute for Medical Research)
Cited by 25
Related Papers
Therapeutic strategies for COVID-19: progress and lessons learned
|Nature Reviews Drug Discovery|2023|671
Antiviral agents active against influenza A viruses
|Nature Reviews Drug Discovery|2006|666
Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding
|Journal of Clinical Investigation|2007|331
Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia
|Blood|2012|300
Overview of Recent Strategic Advances in Medicinal Chemistry
|Journal of Medicinal Chemistry|2019|181